Analysed TAKEDA PHARMACEUTICAL CO LTD (TKPHF:OTCMKTS) News Sources
Immunovant’s potential autoimmune ‘blockbuster’; Wave’s RNA editing update
20-05-2026
biopharmadive.com
Takeda faces $885m hit after landmark pay-for-delay lawsuit verdict
20-05-2026
pharmaceutical-technology.com
2026 ASCO Abstract Highlights: Innovent Biologics' IBI363 (PD-1/IL-2α-bias bispecific fusion protein) Demonstrates Robust Survival Benefits in Long-Term Follow-up of PoC Study in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer
21-05-2026
yahoo.com
What is the current price of TAKEDA PHARMACEUTICAL CO LTD (TKPHF:OTCMKTS)?
The current price of TAKEDA PHARMACEUTICAL CO LTD (TKPHF:OTCMKTS) is $32.1.
TAKEDA PHARMACEUTICAL CO LTD (TKPHF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of TAKEDA PHARMACEUTICAL CO LTD (TKPHF:OTCMKTS) since the previous trading day is $-0.5.
TAKEDA PHARMACEUTICAL CO LTD (TKPHF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of TAKEDA PHARMACEUTICAL CO LTD (TKPHF:OTCMKTS) since the previous trading day is -1.5337%.
What is the most recent average sentiment score for TAKEDA PHARMACEUTICAL CO LTD (TKPHF:OTCMKTS)?
The most recent average sentiment score for TAKEDA PHARMACEUTICAL CO LTD (TKPHF:OTCMKTS) is 55 out of 100.
What is the most recent average sentiment for TAKEDA PHARMACEUTICAL CO LTD (TKPHF:OTCMKTS)?
The most recent sentiment for TAKEDA PHARMACEUTICAL CO LTD (TKPHF:OTCMKTS) is .
SEC-8K** Filing Available For TAKEDA PHARMACEUTICAL CO LTD (TKPHF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.